Analysts Set Billiontoone, Inc. (NASDAQ:BLLN) Target Price at $135.29

Billiontoone, Inc. (NASDAQ:BLLN) has received an average rating of “Moderate Buy” from the nine ratings firms that are covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $135.2857.

BLLN has been the topic of several recent analyst reports. Wall Street Zen raised Billiontoone to a “hold” rating in a report on Saturday, November 15th. JPMorgan Chase & Co. dropped their price objective on Billiontoone from $150.00 to $145.00 and set an “overweight” rating on the stock in a research note on Wednesday, December 10th. BTIG Research reaffirmed a “buy” rating and set a $160.00 target price on shares of Billiontoone in a research note on Wednesday, December 10th. Wells Fargo & Company began coverage on shares of Billiontoone in a research report on Monday, December 1st. They issued an “equal weight” rating and a $110.00 price target on the stock. Finally, Piper Sandler restated an “overweight” rating on shares of Billiontoone in a research report on Wednesday, December 10th.

Billiontoone Trading Down 1.6%

Shares of NASDAQ BLLN opened at $86.18 on Tuesday. Billiontoone has a fifty-two week low of $80.00 and a fifty-two week high of $138.70. The company’s 50-day moving average is $97.97. The company has a market capitalization of $3.94 billion and a PE ratio of 861.80.

Billiontoone (NASDAQ:BLLN) last released its earnings results on Tuesday, December 9th. The company reported $0.10 EPS for the quarter, missing the consensus estimate of $0.16 by ($0.06). The business had revenue of $83.52 million for the quarter, compared to analysts’ expectations of $82.86 million.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Green Alpha Advisors LLC acquired a new stake in shares of Billiontoone during the 4th quarter valued at $436,000. FNY Investment Advisers LLC acquired a new stake in shares of Billiontoone during the fourth quarter worth $497,000. Massachusetts Financial Services Co. MA purchased a new stake in shares of Billiontoone during the fourth quarter valued at $13,373,000. Finally, Baillie Gifford & Co. acquired a new position in shares of Billiontoone in the 4th quarter valued at $103,786,000.

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.